Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug

Takara Bio Inc. world leader in biotechnology R&D, announces that it has entered into a License and Supply Agre...

June 25, 2021 | Friday | News
Novasep invests $7.3M in API manufacturing facility in France

Novasep, a leading supplier of services and technologies for the life sciences industry, announced a €6.1 million (...

June 24, 2021 | Thursday | News
Centrient Pharma boosts statins API manufacturing capacity in India

Centrient Pharmaceuticals, headquartered in the Netherlands, has announced to have started production at its new statins...

June 21, 2021 | Monday | News
UK Pharma firm invests $219M to scale up respiratory drug in China, Taiwan, HK, Macau

Verona Pharma plc and Nuance Pharma Limited have entered into an agreement granting Nuance Pharma, a Shanghai-based...

June 10, 2021 | Thursday | News
Vetter bags Axia Best Managed Companies Award, second time in a row

For the second time in a row, Vetter, a global leading contract development and manufacturing organisation (CDMO), ...

May 26, 2021 | Wednesday | News
Hummingbird Bioscience raises US$125 Million with international biotech investors

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against h...

May 25, 2021 | Tuesday | News
BioNTech to establish first South East Asia HQ in Singapore

German firm BioNTech has announced plans to expand its global footprint to Asia with the establishment of its Regional H...

May 10, 2021 | Monday | News
SESTO Robotics expands to Europe, targeting Germany, Austria, Switzerland

Singapore’s leading autonomous mobile robot company SESTO Robotics (SESTO) has expanded to Europe, partnering with...

May 6, 2021 | Thursday | News
Zenas BioPharma launches as a cross-border Biopharma company

Zenas BioPharma has launched a cross-border biopharmaceutical company committed to becoming a global leader in the devel...

April 30, 2021 | Friday | News
Hilco Industrial acquires Legacy Pharmaceutical assets in Switzerland

Hilco Industrial Acquisitions, an Amsterdam-based Industrial Asset Disposition and Acquisition Company, acquired al...

April 30, 2021 | Friday | News
India's Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment

The company’s subsidiary, Carbogen Amcis AG, pharmaceutical process development and Active Pharmaceutical Ingredie...

April 29, 2021 | Thursday | News
Sanofi and C4X Discovery ink €414 M worldwide licensing deal

Sanofi and drug discovery company C4X Discovery (C4XD) have entered an exclusive worldwide licensing agreement worth up ...

April 16, 2021 | Friday | News
Sanofi invests in Asia's first digitally-enabled vaccine production center in Singapore

Sanofi has announced a €400 million investment over five years to create a unique vaccine production center in Sing...

April 12, 2021 | Monday | News
High Purity New England expands distribution to Northern California with Optimal Biotech

High Purity New England, a leading supplier of single-use solutions for the biopharmaceutical industry announced that ...

April 7, 2021 | Wednesday | News
Ajinomoto Bio-Pharma expands manufacturing agreement with AstraZeneca

Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services w...

March 31, 2021 | Wednesday | News
Chime Biologics completes US$190M Series A+ financing to accelerate capacity expansion

Chime Biologics, a China-based, world-class CDMO company, announced that it has secured a total commitment of ...

March 26, 2021 | Friday | News
Bioheng Biotech to advance Allogeneic Immuno-Cell Therapies

Bioheng Biotech Co., Ltd, a clinical-stage biotechnology company dedicated to developing novel cellular immuno...

March 25, 2021 | Thursday | News
Waters BioAccord system boosts biosimilar drug development and commercialization

Waters Corporation introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord&t...

March 21, 2021 | Sunday | News